Next Generation Therapeutics for the Treatment of Myelofibrosis
16429
post-template-default,single,single-post,postid-16429,single-format-standard,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.0.9,qode-theme-bridge,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

Next Generation Therapeutics for the Treatment of Myelofibrosis

Home > Blogs  > Next Generation Therapeutics for the Treatment of Myelofibrosis

20 Nov Next Generation Therapeutics for the Treatment of Myelofibrosis

Posted at 10:13h in Blogs by

Multiple non-JAK inhibitor-based therapies are being explored in pre-clinical and clinical settings for the treatment of myelofibrosis, targeting outside of the JAK-STAT pathway. (Ref: Tremblay D et al. Cells. 2021)
#oncologyresearch

https://www.linkedin.com/feed/update/urn:li:activity:6867852221321658368

No Comments

Sorry, the comment form is closed at this time.